MYBL2 and hepatocellular carcinoma: The article found that MYBL2 was a downstream target of miR‐30c‐2‐3p and was highly expressed in LUAD tissues with the capable of predicting a poor prognosis, which was consistent with the studies in esophageal squamous cell carcinoma (25), HCC (26) and pancreatic ductal carcinoma (27).